News

Syros seeking new partner for its SCD program after Pfizer ends deal

Pfizer has decided to end a treatment discovery program with Syros Pharmaceuticals that it inherited after acquiring Global Blood Therapeutics (GBT) last year, leaving Syros to seek another partner for the program, which targets two blood disorders, including sickle cell disease (SCD). The agreement termination was announced…

Scribe, Sanofi expand research collaboration

Genetic medicines company Scribe Therapeutics has expanded its collaboration with Sanofi to advance the development of a new wave of in vivo treatments for sickle cell disease (SCD) and other disorders. The collaboration leverages Scribe’s proprietary CRISPR X-Editing technologies and Sanofi’s targeted non-viral delivery technologies for the…

SCDAA, MedicAlert working to improve emergency care

The Sickle Cell Disease Association of America (SCDAA) and the MedicAlert Foundation are partnering on a pilot program to help those living with sickle cell disease (SCD) receive faster and better emergency care. With the aim of improving the safety and well-being of patients during acute pain…

Nikkolas Smith portrait aims to boost blood donations for SCD

A digital portrait created by artist Nikkolas Smith for the American Red Cross seeks to heighten awareness of sickle cell disease (SCD) and the ongoing need for blood donations for SCD patients, particularly from Black donors. The artwork, titled “Transfusion,” depicts a young African American person crossing their hands,…